buspirone has been researched along with Depression in 48 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo." | 9.34 | Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020) |
| "We conducted a 24-week, randomized, double-blind parallel-controlled trial to test whether buspirone is beneficial to improve cognitive deficits of schizophrenia because it remains unclear." | 9.30 | Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia. ( Deng, W; Guo, W; Li, T; Ma, X; Song, X; Tian, H; Wang, J; Wang, Q; Wang, Y; Wei, J; Wei, M; Yang, X; Zhao, L; Zheng, C, 2019) |
| "To evaluate the efficacy of buspirone hydrochloride, a serotonin (5-hydroxytryptamine1A) agonist, in treating patients with cerebellar ataxia." | 9.08 | Use of buspirone for treatment of cerebellar ataxia. An open-label study. ( Gatev, P; Goldfarb, L; Hallett, M; Lou, JS; McShane, L, 1995) |
| "The aim of this study was to explore the efficacy of buspirone (BSR), in comparison with amitriptyline (AML) in the prophylactic treatment of chronic tension-type headache (CTH), in an open and randomized clinical trial." | 9.08 | Buspirone vs amitriptyline in the treatment of chronic tension-type headache. ( Gatzonis, S; Ilias, A; Mitsikostas, DD; Thomas, A, 1997) |
| "To report a case of acute dystonia consisting of neck stiffness, trismus, and unilateral temporomandibular joint (TMJ) pain and subluxation secondary to an increase in sustained-release (SR) bupropion." | 7.71 | Bupropion-induced acute dystonia. ( Detweiler, MB; Harpold, GJ, 2002) |
| " Buspirone was administered to 16 depressed poststroke (DPS), 10 non-depressed post-stroke (NDPS) patients, and 10 male healthy controls (HCs), to evaluate serotonin (5-HT) function." | 7.70 | The prolactin response to buspirone in poststroke depression: a preliminary report. ( Erol, A; Sevinçok, L, 2000) |
| "or s." | 5.72 | The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. ( Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A, 2022) |
| "Buspirone was injected to female rats from the 9th to 21st days of pregnancy; during the last week of pregnancy buspirone was injected 10 min before immobilization stress." | 5.36 | [Effects of prenatal influences of buspirone and stress on indices of inflammatory pain response and depressive behaviour in adult rats]. ( Butkevich, IP; Mikhaĭlenko, VA; Otellin, VA; Semenov, PO; Vershinina, EA, 2010) |
| "Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo." | 5.34 | Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020) |
| "We conducted a 24-week, randomized, double-blind parallel-controlled trial to test whether buspirone is beneficial to improve cognitive deficits of schizophrenia because it remains unclear." | 5.30 | Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia. ( Deng, W; Guo, W; Li, T; Ma, X; Song, X; Tian, H; Wang, J; Wang, Q; Wang, Y; Wei, J; Wei, M; Yang, X; Zhao, L; Zheng, C, 2019) |
| "To evaluate the efficacy of buspirone hydrochloride, a serotonin (5-hydroxytryptamine1A) agonist, in treating patients with cerebellar ataxia." | 5.08 | Use of buspirone for treatment of cerebellar ataxia. An open-label study. ( Gatev, P; Goldfarb, L; Hallett, M; Lou, JS; McShane, L, 1995) |
| "The aim of this study was to explore the efficacy of buspirone (BSR), in comparison with amitriptyline (AML) in the prophylactic treatment of chronic tension-type headache (CTH), in an open and randomized clinical trial." | 5.08 | Buspirone vs amitriptyline in the treatment of chronic tension-type headache. ( Gatzonis, S; Ilias, A; Mitsikostas, DD; Thomas, A, 1997) |
| "Thirty outpatients meeting DSM-III-R or DSM-IV criteria for major depression, single or recurrent episode, and failing to respond to an adequate trial of an antidepressant (>6 weeks at recommended dosage) received buspirone (20-30 mg/day) for 4 or 5 weeks in addition to their existing antidepressant." | 5.08 | Buspirone augmentation of antidepressant therapy. ( Dimitriou, CE; Dimitriou, EC, 1998) |
| "To report a case of acute dystonia consisting of neck stiffness, trismus, and unilateral temporomandibular joint (TMJ) pain and subluxation secondary to an increase in sustained-release (SR) bupropion." | 3.71 | Bupropion-induced acute dystonia. ( Detweiler, MB; Harpold, GJ, 2002) |
| " Buspirone was administered to 16 depressed poststroke (DPS), 10 non-depressed post-stroke (NDPS) patients, and 10 male healthy controls (HCs), to evaluate serotonin (5-HT) function." | 3.70 | The prolactin response to buspirone in poststroke depression: a preliminary report. ( Erol, A; Sevinçok, L, 2000) |
| "The influence of alpha 2-adrenoceptor blockade on the activity of desipramine in an experimental model of depression was studied by using idazoxan and 1-(pyrimidinyl)piperazine (1-PP)." | 3.68 | Alpha 2-adrenoceptor blockade prevents the effect of desipramine in the forced swimming test. ( Cervo, L; Grignaschi, G; Samanin, R, 1990) |
| "Buspirone-treated patients averaged a 12." | 2.68 | Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. ( Amsterdam, JD; Cutler, NR; Hornig-Rohan, M; Sramek, JJ; Stahl, SM; Suri, A; Tansman, M; Weisler, RH, 1996) |
| "Buspirone has an indication for generalized anxiety disorder though studies show only a minimal benefit." | 2.53 | Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD. ( Bielefeldt, K; Szigethy, E; Thorkelson, G, 2016) |
| " In patients who have experienced only partial treatment results, the clinician should first consider optimizing antidepressant dosage or lengthening therapy." | 2.40 | Practical management of treatment-resistant depression. ( Cadieux, RJ, 1998) |
| "or s." | 1.72 | The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. ( Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A, 2022) |
| "Buspirone was injected to female rats from the 9th to 21st days of pregnancy; during the last week of pregnancy buspirone was injected 10 min before immobilization stress." | 1.36 | [Effects of prenatal influences of buspirone and stress on indices of inflammatory pain response and depressive behaviour in adult rats]. ( Butkevich, IP; Mikhaĭlenko, VA; Otellin, VA; Semenov, PO; Vershinina, EA, 2010) |
| "Pretreatment with buspirone (0." | 1.30 | Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. ( Bourin, M; Redrobe, JP, 1998) |
| "Prospective comparison of patients with postviral fatigue syndrome with two control groups." | 1.28 | Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. ( Bakheit, AM; Behan, PO; Dinan, TG; Gray, CE; O'Keane, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.33) | 18.7374 |
| 1990's | 21 (43.75) | 18.2507 |
| 2000's | 9 (18.75) | 29.6817 |
| 2010's | 11 (22.92) | 24.3611 |
| 2020's | 3 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bojarski, AJ | 1 |
| Kuran, B | 1 |
| Kossakowski, J | 1 |
| Kozioł, A | 1 |
| Jagiełło-Wójtowicz, E | 1 |
| Chodkowska, A | 1 |
| Jastrzębska-Więsek, M | 1 |
| Wesołowska, A | 1 |
| Kołaczkowski, M | 1 |
| Varney, MA | 1 |
| Newman-Tancredi, A | 1 |
| Depoortere, R | 1 |
| Wang, R | 1 |
| Fu, M | 1 |
| Savini, G | 1 |
| Zhao, J | 1 |
| Zhang, H | 2 |
| Badihian, N | 1 |
| Yaghini, O | 1 |
| Badihian, S | 1 |
| Shahsanai, A | 1 |
| Saneian, H | 1 |
| Nunes, JC | 1 |
| Botas, JL | 1 |
| Knapp, P | 1 |
| Campbell Burton, CA | 1 |
| Holmes, J | 1 |
| Murray, J | 1 |
| Gillespie, D | 1 |
| Lightbody, CE | 1 |
| Watkins, CL | 1 |
| Chun, HY | 1 |
| Lewis, SR | 1 |
| Mikhailenko, VA | 2 |
| Butkevich, IP | 2 |
| Wang, Y | 1 |
| Yang, X | 1 |
| Song, X | 1 |
| Zhao, L | 1 |
| Wei, J | 1 |
| Wang, J | 1 |
| Tian, H | 1 |
| Zheng, C | 1 |
| Wei, M | 1 |
| Wang, Q | 1 |
| Guo, W | 1 |
| Deng, W | 1 |
| Li, T | 1 |
| Ma, X | 1 |
| Laver, B | 1 |
| Diwan, M | 1 |
| Nobrega, JN | 1 |
| Hamani, C | 1 |
| Fomina, MK | 1 |
| Avgustinovich, DF | 2 |
| Tolstikova, TG | 1 |
| Kirilly, E | 1 |
| Gonda, X | 1 |
| Bagdy, G | 1 |
| Levin, OS | 1 |
| Thorkelson, G | 1 |
| Bielefeldt, K | 1 |
| Szigethy, E | 1 |
| Wang, W | 1 |
| Jiang, Z | 1 |
| Shang, J | 1 |
| Zhang, L | 1 |
| Vershinina, EA | 1 |
| Semenov, PO | 1 |
| Otellin, VA | 1 |
| Bond, AJ | 1 |
| Wingrove, J | 1 |
| Baylis, M | 1 |
| Dalton, J | 1 |
| Alekseyenko, OV | 1 |
| Koryakina, LA | 1 |
| Jägestedt, M | 1 |
| von Bahr, C | 1 |
| Newton, RE | 1 |
| Casten, GP | 1 |
| Alms, DR | 1 |
| Benes, CO | 1 |
| Marunycz, JD | 1 |
| Goldberg, HL | 1 |
| Finnerty, R | 1 |
| Lou, JS | 1 |
| Goldfarb, L | 1 |
| McShane, L | 1 |
| Gatev, P | 1 |
| Hallett, M | 1 |
| Sramek, JJ | 1 |
| Tansman, M | 1 |
| Suri, A | 1 |
| Hornig-Rohan, M | 1 |
| Amsterdam, JD | 1 |
| Stahl, SM | 1 |
| Weisler, RH | 1 |
| Cutler, NR | 1 |
| Blier, P | 1 |
| Bergeron, R | 1 |
| Frischauf, E | 1 |
| Mitsikostas, DD | 1 |
| Gatzonis, S | 1 |
| Thomas, A | 1 |
| Ilias, A | 1 |
| Lawlor, B | 1 |
| Redrobe, JP | 1 |
| Bourin, M | 1 |
| Lader, M | 1 |
| Scotto, JC | 1 |
| Cadieux, RJ | 1 |
| Dimitriou, EC | 1 |
| Dimitriou, CE | 1 |
| Sevinçok, L | 1 |
| Erol, A | 1 |
| Magill, MK | 1 |
| Gunning, K | 1 |
| Lantz, MS | 1 |
| Detweiler, MB | 1 |
| Harpold, GJ | 1 |
| Spinella, M | 1 |
| Eaton, LA | 1 |
| Flugy, A | 1 |
| Gagliano, M | 1 |
| Cannizzaro, C | 1 |
| Novara, V | 1 |
| Cannizzaro, G | 1 |
| Kostowski, W | 1 |
| Dyr, W | 1 |
| Krzascik, P | 1 |
| Järbe, T | 1 |
| Archer, T | 1 |
| Bakheit, AM | 1 |
| Behan, PO | 1 |
| Dinan, TG | 1 |
| Gray, CE | 1 |
| O'Keane, V | 1 |
| Hatcher, S | 1 |
| Curtis, D | 1 |
| Bullock, T | 1 |
| Kennett, GA | 1 |
| Wells, BG | 1 |
| Chu, CC | 1 |
| Johnson, R | 1 |
| Nasdahl, C | 1 |
| Ayubi, MA | 1 |
| Sewell, E | 1 |
| Statham, P | 1 |
| Cervo, L | 1 |
| Grignaschi, G | 1 |
| Samanin, R | 1 |
| Boylan, K | 1 |
| Cohn, JB | 1 |
| Bowden, CL | 1 |
| Fisher, JG | 1 |
| Rodos, JJ | 1 |
| Goa, KL | 1 |
| Ward, A | 1 |
6 reviews available for buspirone and Depression
| Article | Year |
|---|---|
Interventions for treating anxiety after stroke.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Depression; Humans; Middle Aged; Par | 2017 |
[Antidepressants, stressors and the serotonin 1A receptor].
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Depression; Depressive Disorder; Dep | 2015 |
Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Topics: Adolescent; Adult; Affect; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Bupropion | 2016 |
Practical management of treatment-resistant depression.
Topics: Antidepressive Agents; Buspirone; Depression; Drug Resistance; Drug Therapy, Combination; Humans; Li | 1998 |
Mechanisms of serotonergic affect control.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Busp | 1991 |
Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Buspirone; Depression; Diazepam; Drug Administration | 1986 |
11 trials available for buspirone and Depression
| Article | Year |
|---|---|
Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial.
Topics: Abdominal Pain; Adolescent; Anxiety; Buspirone; Child; Depression; Female; Humans; Male; Pain Measur | 2020 |
Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Anxiety; Buspirone; Cognition; Cognitive Dysfunction; Depre | 2019 |
Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli.
Topics: Administration, Oral; Adolescent; Adult; Anxiety; Buspirone; Conditioning, Classical; Depression; Do | 2003 |
The side effect profile of buspirone in comparison to active controls and placebo.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium | 1982 |
Comparison of buspirone in two separate studies.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotass | 1982 |
Use of buspirone for treatment of cerebellar ataxia. An open-label study.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Buspirone; Cerebellar Ataxia; Depression; Female; Humans; | 1995 |
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Topics: Adult; Anxiety Disorders; Buspirone; Comorbidity; Depression; Dizziness; Double-Blind Method; Female | 1996 |
Buspirone vs amitriptyline in the treatment of chronic tension-type headache.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Buspirone; Dep | 1997 |
A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Depression; Double-Blind | 1998 |
Buspirone augmentation of antidepressant therapy.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Buspirone; Clomipramine; Depression; Female | 1998 |
Double-blind comparison of buspirone and clorazepate in anxious outpatients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cl | 1986 |
31 other studies available for buspirone and Depression
| Article | Year |
|---|---|
Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Mice; Receptor, Serotonin, 5-HT1A; Receptor, Se | 2009 |
The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Buspirone; Catalepsy; Depres | 2022 |
Pupillary capture of implantable collamer lens after oral antidepressants.
Topics: Administration, Oral; Adult; Antidepressive Agents; Buspirone; Depression; Drug Therapy, Combination | 2019 |
A Serotonin "Cocktail".
Topics: Buspirone; Citalopram; Depression; Drug Therapy, Combination; Female; Humans; Middle Aged; Selective | 2020 |
Prenatal Stimulation of 5-HT
Topics: Adaptation, Psychological; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Buspirone; Depressi | 2019 |
Augmentative therapies do not potentiate the antidepressant-like effects of deep brain stimulation in rats.
Topics: Animals; Behavior, Animal; Buspirone; Deep Brain Stimulation; Depression; Dopamine Antagonists; Gyru | 2014 |
[Effects of buspirone complex with glycyrrhizic acid on behavior of mice with anxious-depressive state].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Buspirone; Depression; Glycyrrhizic | 2014 |
[The use of buspirone in clinical practice].
Topics: Anti-Anxiety Agents; Anxiety; Buspirone; Depression; Dyskinesia, Drug-Induced; Humans; Parkinson Dis | 2015 |
Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Depression; Fluoxetine; Interferon-alpha | 2010 |
[Effects of prenatal influences of buspirone and stress on indices of inflammatory pain response and depressive behaviour in adult rats].
Topics: Animals; Behavior, Animal; Buspirone; Depression; Female; Immobilization; Inflammation; Male; Pain; | 2010 |
Effects of chronic treatment with ipsapirone and buspirone on the C57BL/6J strain mice under social stress.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Buspirone; Depression; Interpersonal Relations; Male | 2003 |
[Combination of serotonergic agents resulted in severe adverse effects].
Topics: Antidepressive Agents, Second-Generation; Buspirone; Cytochrome P-450 CYP2D6; Depression; Drug Inter | 2004 |
Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings.
Topics: Adrenergic beta-Antagonists; Adult; Buspirone; Depression; Drug Resistance; Drug Therapy, Combinatio | 1996 |
Drug therapy in autism.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Autistic Disorder; Buspirone; Child; Depression; Drug The | 1997 |
[Anxiety and depression. Highlights from the 149th Session of the American Psychiatric Association, New York 4-9 May 1996].
Topics: Anti-Anxiety Agents; Anxiety; Benzodiazepines; Buspirone; Depression; Humans; Psychiatry; Serotonin | 1997 |
'The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia'--1997, 12, 519-527.
Topics: Buspirone; Dementia; Depression; Drug Therapy, Combination; Humans; Psychotic Disorders; Selective S | 1998 |
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Resp | 1998 |
The prolactin response to buspirone in poststroke depression: a preliminary report.
Topics: Adult; Aged; Buspirone; Case-Control Studies; Depression; Dominance, Cerebral; Female; Humans; Male; | 2000 |
Generalized anxiety disorder in family practice patients.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Depression; Diagn | 2000 |
Serotonin syndrome. A common but often unrecognized psychiatric condition.
Topics: Aged; Anxiety Disorders; Buspirone; Citalopram; Depression; Female; Humans; Selective Serotonin Reup | 2001 |
Bupropion-induced acute dystonia.
Topics: Acute Disease; Adult; Bupropion; Buspirone; Depression; Dopamine Uptake Inhibitors; Dose-Response Re | 2002 |
Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury.
Topics: Adult; Anti-Anxiety Agents; Bipolar Disorder; Brain Injuries; Buspirone; Depression; Drug Interactio | 2002 |
Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Depression; Desipramine; | 1992 |
5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Buspirone; Chromans; Depression; Disease M | 1992 |
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.
Topics: Adult; Buspirone; Depression; Diagnosis, Differential; Fatigue Syndrome, Chronic; Female; Humans; Hy | 1992 |
Postviral fatigue syndrome.
Topics: Buspirone; Depression; Diagnosis, Differential; Fatigue Syndrome, Chronic; Humans | 1992 |
Postviral fatigue syndrome.
Topics: Buspirone; Depression; Diagnosis, Differential; Fatigue Syndrome, Chronic; Humans; Prolactin | 1992 |
Buspirone in the treatment of posttraumatic stress disorder.
Topics: Aged; Anxiety; Buspirone; Depression; Dreams; Humans; Male; Middle Aged; Sleep Initiation and Mainte | 1991 |
Alpha 2-adrenoceptor blockade prevents the effect of desipramine in the forced swimming test.
Topics: Adrenergic alpha-Antagonists; Animals; Buspirone; Depression; Desipramine; Dioxanes; Hydroxydopamine | 1990 |
Serotonin partial agonists in the treatment of anxiety and depression. Proceedings from the VIII World Congress of Psychiatry. Athens, Greece, October 12-19, 1989.
Topics: Anxiety; Buspirone; Depression; Humans | 1990 |
Persistent dystonia associated with buspirone.
Topics: Anxiety; Buspirone; Depression; Drug Therapy, Combination; Dystonia; Female; Follow-Up Studies; Huma | 1990 |